查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2133421

ACL/PCL重組市場規模、佔有率和趨勢分析 |全球| 2026–2032 | 包括移植物和固定裝置

ACL/PCL Reconstruction Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Grafts and Fixation Devices
出版日期: | 出版商: iData Research Inc. | 英文 104 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年全球ACL/PCL重組市場價值約13億美元。預計該市場將以6.0%的複合年成長率成長，到2032年將超過20億美元。

本報告涵蓋了前十字韌帶/後十字韌帶重組中使用的同種異體移植物和固定裝置。同種異體移植物依類型分為骨-膝腱-骨（BTB）移植物、未縫合軟組織移植物及縫合軟組織移植物。固定裝置依類型分為阻斷式骨釘、皮質骨固定裝置、隧道固定裝置、墊片柱和交叉釘。本報告定量分析了銷售量、手術例數、平均售價（ASP）、市場規模、成長率和企業市場占有率，並包含截至2022年的歷史數據和截至2032年的預測數據。

2025年，先進的固定技術將持續推動市場發展。可調節的環狀皮質骨固定裝置使外科醫生能夠在手術過程中調整移植物的張力，以匹配患者獨特的隧道長度和直徑，從而在保持移植物完整性的同時，擴大了可用的移植物選擇範圍。無縫合軟組織同種異體移植仍然是骨-骨-骨-骨（BTB）同種異體移植的一種經濟有效的替代方案，尤其是在手術效率至關重要的門診環境中。

體育產業仍然是重要的商業性驅動力，製造商與職業體育組織保持夥伴關係，這些組織為研發、臨床試驗和外科培訓項目提供資金。這些合作加速了新一代固定裝置的應用，並擴大了用於改進解剖重組技術的臨床證據基礎。

市場概覽

全球ACL/PCL重組市場是整形外科運動醫學領域最具活力的細分市場之一，其成長主要受運動員和經常鍛鍊人群韌帶損傷高發以及重組中對解剖學精準性和生物整合性日益重視的驅動。該市場涵蓋用於替代受損韌帶的移植物產品以及將這些移植物固定在骨隧道內的固定裝置，產品創新主要集中在這兩個類別。

過去十年，固定技術取得了顯著進展。可調式環狀皮質骨懸吊裝置因其柔軟性、易於放置以及可靠的皮質骨固定強度，正逐漸取代阻斷式骨釘，佔據越來越多的市場佔有率。透過微調環長以匹配患者獨特的隧道形狀，減少了移植物尺寸調整的需要，並維持了動態完整性。這在解剖重組中尤其重要，因為移植物直徑是決定穩定性和斷裂風險的關鍵因素。生物複合材料和PEEK阻斷式骨釘仍然廣泛應用於隧道和骨間固定，而有助於骨內移植物插入的開放式結構設計也日益受到關注。

目前移植材料的現狀反映了同種異體移植材料的可用性和自體移植材料的性能之間的平衡。自體移植材料具有更優異的生物相容性和較低的失敗率，尤其適用於活動量大的患者群體；而同種異體移植材料則因其更高的手術效率，在某些特定患者群體和門診環境中更受歡迎。供體組織供應的限制限制了同種異體移植材料市場的成長，對特定供體肌腱的需求始終超過現有供應和處理能力。在工作流程效率至關重要的環境中，無縫線和預製軟組織同種異體移植材料仍然是骨-骨（BTB）結構的一種經濟有效的替代方案。

大多數前十字韌帶/後十字韌帶重組手術都在日間手術中心和其他門診診所進行。這些機構優先考慮高效且經濟的關節鏡手術，由於與醫院相比，它們面臨更嚴格的營運成本和更低的報銷率，醫療設備的價格持續面臨下行壓力。這種環境影響產品的選擇和設計重點，能夠提高手術效率並維持臨床療效的系統更受青睞。

市場促進因素

體育產業

ACL/PCL重組市場的製造商正與職業運動組織密切合作，以確保治療方案始終保持臨床最新水平，並針對高水平運動員進行最佳化。這些夥伴關係為研發、臨床試驗和長期療效夥伴關係提供資金支持，從而為新的固定方法和移植方案提供實證依據。此外，他們也資助專業外科醫生進修計畫和教育計劃，以提升各種臨床環境下的重組技術。史密斯醫療（Smith & Nephew）與UFC的長期夥伴關係便是這一模式近期的典型例子。透過在以競技表現為導向的環境中向手術量大的外科醫生推廣新產品，這些合作加速了產品在臨床實踐中的應用，並支持對下一代重組技術的持續投資。

高級固定期權

固定技術的進步進一步拓展了移植物的多功能性，使得ACL和PCL重建手術都能實現更高品質的解剖重組。可調式環狀皮質懸吊裝置的使用，允許術中根據每位患者不同的隧道長度和移植物直徑調整張力，從而減少軟組織同種異體移植物的調整需求，並在整個手術過程中保持移植物完整性。這些系統的轉變反映了人們越來越重視精確張力控制的臨床價值以及解剖隧道定位的可重複性。雖然隧道內螺絲和阻斷式骨釘仍在繼續使用，但隨著外科醫生根據移植物類型和解剖結構調整固定策略，對生物複合材料和PEEK平台的需求持續成長。由於新一代固定平台的平均售價通常更高，預計在整個預測期內，向可調節皮質固定系統和生物整合植入的持續轉變將推動整體市場價值的成長。

市場限制

供不應求

對捐贈者肌腱的需求持續成長，但同種異體移植的供應量仍遠遠超過需求。特定供體肌腱的供應始終無法完全保證，而且同種異體移植的使用受到組織處理的複雜性以及供體年齡和移植尺寸等特定限制的阻礙，這些限制因患者群體而異。儘管安全標準和消毒技術已顯著提高，但與自體移植相比，疾病傳播和組織排斥的風險仍然存在。由於自體移植具有更優的生物相容性和更低的移植失敗率（尤其是在活躍患者中），因此，在預測期內，由於供應方面的限制以及臨床上對年輕和高需求患者群體更傾向於使用自體組織，同種異體移植市場的成長將繼續受到抑制。

ASC的門診護理環境與價格壓力

全球絕大多數前十字韌帶 (ACL) 和後十字韌帶 (PCL)重組手術都在門診手術中心 (ASC) 和其他門診機構進行。與傳統醫院相比，這些機構的營運成本和報銷率顯著較低，因此它們優先採用高效且經濟的關節鏡手術技術以維持盈利。這種環境持續對醫療設備價格構成下行壓力，抑制了固定植入和同種異體移植物的價格上漲。在這種環境下，成熟且具成本競爭力的產品往往比高階產品更受歡迎，導致平均售價 (ASP) 的提升速度放緩，並限制了高價新一代植入在高流量門診機構的商業性成長潛力。

目錄

調查方法

  • 第一步：專案啟動與團隊組建
  • 步驟二：資料系統開發與二次調查實施
  • 步驟三：準備面試設計問卷
  • 第四步：進行初步調查
  • 第五步：調查分析：基準估計
  • 第六步：市場預測與分析
  • 第七步：辨識策略機遇
  • 步驟 8：最終確認和市場發布
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

ACL/PCL重組市場

  • 執行摘要
    • 全球ACL/PCL重組市場概覽
    • 競爭分析
    • 目標市場
    • 目標區域
  • 介紹
  • 手術次數
  • 市場概覽
    • 按細分市場
    • 按地區
  • 市場分析與預測
    • ACL/PCL重組總市場
    • 同種異體移植市場
    • 固定設備市場
  • 促進因素和抑制因素
    • 市場促進因素
    • 市場限制因素
  • 競爭性市佔率分析

簡稱

Product Code: iDATA_GLOST26_ACL_MC

The global ACL/PCL reconstruction market was valued at approximately $1.3 billion in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 6.0%, reaching over $2 billion by 2032.

This report covers allografts and fixation devices used in ACL and PCL reconstruction procedures. Allografts are segmented by type into bone-patella tendon bone (BTB), non-sutured soft tissue, and pre-sutured soft tissues. Fixation devices are segmented by type into interference screws, cortical fixation, intratunnel fixation, washer and post, and cross-pins. The report quantifies unit sales, procedure numbers, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.

Advanced fixation technologies continued to drive market development in 2025. Adjustable loop cortical fixation devices allow surgeons to match graft tensioning to patient-specific tunnel length and diameter intraoperatively, preserving graft integrity and expanding the range of viable graft options. Non-sutured soft tissue allografts remained a cost-effective alternative to BTB allografts, particularly in outpatient settings prioritizing procedural efficiency.

The sports industry remains a key commercial driver, with manufacturers maintaining partnerships with professional sports organizations that fund research and development, clinical trials, and surgical training programs. These collaborations accelerate the adoption of next-generation fixation devices and expand the clinical evidence base for improved anatomic reconstruction techniques.

Market Overview

The global ACL/PCL reconstruction market is one of the most active segments within orthopedic sports medicine, supported by a high volume of ligament injuries across athletic and active populations and a growing emphasis on anatomic precision and biological integration in reconstruction technique. The market encompasses both the graft products used to replace damaged ligaments and the fixation devices that secure those grafts within bone tunnels, with product innovation concentrated across both categories.

Fixation technology has evolved considerably over the past decade. Adjustable loop cortical suspension devices are gaining market share over interference screws due to their intraoperative tensioning flexibility, ease of deployment, and reliable cortical fixation strength. The ability to fine-tune loop length to match patient-specific tunnel geometry reduces the need to resize grafts and preserves biomechanical integrity, which is particularly valuable in anatomic reconstructions where graft diameter is a key determinant of stability and retear risk. Biocomposite and PEEK interference screws remain widely used in intratunnel and bone-to-bone fixation, and open architecture designs that support bone ingrowth are gaining traction within this format.

The graft landscape reflects a balance between allograft accessibility and autograft performance. Autografts offer superior biological compatibility and lower failure rates in active populations, but allografts provide procedural efficiency and are preferred in certain patient demographics and outpatient settings. Supply constraints for donor tissue limit allograft market growth, as demand for specific donor tendons consistently outpaces available supply and processing capacity. Non-sutured and preconstructed soft tissue allografts remain a cost-effective alternative to BTB constructs in settings that prioritize streamlined workflows.

A substantial majority of ACL and PCL reconstruction procedures are performed in ambulatory surgery centers or other outpatient settings. These facilities prioritize efficient, cost-effective arthroscopic techniques and operate with tighter overhead and lower reimbursement rates than hospitals, placing consistent downward pressure on device pricing. This environment influences product selection and design priorities, favoring systems that support procedural efficiency while maintaining clinical performance.

Market Drivers

Sports Industry

Manufacturers in the ACL/PCL reconstruction market maintain close collaborations with professional sports organizations to ensure that treatment options remain clinically current and optimized for high-performance patients. These partnerships provide financial backing for research and development, clinical trials, and longitudinal outcome studies that support the evidence base for new fixation approaches and graft protocols. They also fund specialized surgical fellowships and educational programs that improve reconstruction technique across clinical settings. Smith and Nephew's multiyear partnership with the UFC is a recent example of this model in practice. By exposing high-volume surgeons to new products in performance-focused contexts, these collaborations accelerate clinical adoption and support sustained investment in next-generation reconstruction technologies.

Advanced Fixation Options

Improved fixation technologies continue to expand graft versatility and support higher-quality anatomic reconstructions across both ACL and PCL indications. Adjustable loop cortical suspension devices allow intraoperative tensioning matched to patient-specific tunnel length and graft diameter, reducing the need to resize soft tissue allografts and preserving graft integrity throughout the procedure. The ongoing shift toward these systems reflects the clinical value placed on precise tension control and reproducibility in anatomic tunnel positioning. Intratunnel and interference screw formats also demonstrate sustained utilization, with biocomposite and PEEK platforms continuing to grow as surgeons tailor fixation strategy to graft type and anatomy. Because next-generation fixation platforms generally carry higher ASPs, continued procedural migration toward adjustable cortical systems and biologically integrated implants is expected to support overall market value expansion through the forecast period.

Market Limiters

Limited Supply of Allograft

Rising demand for donor tendons continues to outpace the supply of available allografts. The availability of specific donor tendons is never fully guaranteed, and allograft use is constrained by the complexity of tissue processing and specific limitations on donor age and graft dimensions that vary across patient populations. Although safety standards and sterilization techniques have improved significantly, a residual risk of disease transmission or tissue rejection remains compared to autograft material. Because autografts offer superior biological compatibility and lower failure rates in active patients, allograft market growth will remain constrained over the forecast period by both supply-side limitations and the clinical preference for autologous tissue among younger and higher-demand patient populations.

Outpatient Setting and ASC Pricing Pressure

A substantial majority of ACL and PCL reconstruction procedures worldwide are performed in ambulatory surgery centers or other outpatient settings. These facilities operate with significantly tighter overhead and lower reimbursement rates than traditional hospitals and prioritize efficient, cost-effective arthroscopic techniques to maintain profitability. This environment exerts sustained downward pressure on device pricing, limiting price growth across both fixation device and allograft categories. Product selection in these settings often favors established, cost-competitive options over premium alternatives, which constrains the pace of ASP improvement and limits the commercial upside of higher-priced next-generation implants in high-volume outpatient accounts.

Market Coverage and Data Scope

  • Quantitative coverage: Procedure numbers, market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
  • Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, and practice trends shaping demand.
  • Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
  • Data sources: Primary interviews with orthopedic industry leaders and sports medicine surgeons, regulatory data, hospital and ASC procurement data, import and export data, and the iData Research internal database.
  • Care settings: Hospitals, ambulatory surgery centers, and orthopedic specialty clinics.

Markets Covered and Segmentation

ACL/PCL Reconstruction Allograft Market

  • Type: Bone-Patella Tendon Bone (BTB), Non-Sutured Soft Tissue, and Pre-Sutured Soft Tissues

ACL/PCL Reconstruction Fixation Device Market

  • Type: Interference Screw, Cortical Fixation, Intratunnel Fixation, Washer and Post, and Cross-Pins

Each segment is analyzed by unit volume, ASP, and market value, with historical and forecast data provided.

Competitive Analysis

Arthrex led the combined ACL/PCL reconstruction market in 2025 and maintained dominance across every global region. The company's leadership in the fixation device market was driven by the BioComposite interference screw line and the TightRope II adjustable loop system, which allows for precise intraoperative graft tensioning. Arthrex also promoted the InternalBrace technique to provide supplemental support for the healing ligament and the FiberTag TightRope II specifically for quadriceps tendon graft applications. The company also emphasized the QuadPro tendon harvester and FiberRing suture during 2025 to improve procedural efficiency and graft preparation for anatomic reconstructions.

Smith and Nephew remained the second leading competitor in the total ACL/PCL reconstruction market in 2025. The company led the cortical fixation segment with the ULTRABUTTON adjustable fixation family, including the ULTRABUTTON QUAD and ULTRABUTTON BB for diverse graft types, frequently paired with the QUADTRAC Quadriceps Tendon Harvest Guide System to streamline workflows. Smith and Nephew was also a leading competitor in the interference screw category with its BIOSURE screws in PEEK and biocomposite materials. The BIOSURE REGENESORB interference screw gained significant traction during the year due to its open architecture design that supports natural bone ingrowth.

DePuy Synthes remained the third leading company in 2025. Its market position was anchored by leadership in intratunnel fixation through the INTRAFIX ADVANCE Tibial Fastener System, which provides 360-degree graft-to-bone compression. The RIGIDFIX Curve Cross Pin System addresses anatomic femoral fixation, and the MILAGRO ADVANCE Interference Screw in BIOCRYL RAPIDE biocomposite supports bony ingrowth at the repair site. The RIGIDLOOP family was expanded to include the RIGIDLOOP Adjustable Cortical System and RIGIDLOOP BTB Adjustable Cortical System for precise tensioning across both soft tissue and bone-to-bone graft constructs.

Technology and Practice Trends

  • Adjustable loop cortical fixation gaining share: Cortical suspension devices with intraoperative loop adjustment are displacing interference screws in many reconstruction applications, offering tensioning precision and deployment simplicity.
  • Quadriceps tendon graft adoption: Growing clinical interest in quadriceps tendon grafts is driving demand for specialized harvesting guides and fixation systems designed for this graft construct.
  • Biocomposite and PEEK interference screws: Biologically integrated screw materials continue to displace metal options, with open architecture designs supporting bone ingrowth gaining meaningful clinical traction.
  • Anatomic reconstruction techniques: Advances in tunnel positioning and fixation reproducibility are supporting more consistent anatomic ligament placement and improving long-term stability outcomes.
  • Supplemental ligament support: Adoption of supplemental constructs such as the InternalBrace technique is growing for cases where additional healing ligament support is a clinical priority.
  • Non-sutured and preconstructed allografts: Cost-effective soft tissue allograft formats designed for procedural efficiency continue to expand access to allograft reconstruction in outpatient settings.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

  • Where are the largest and fastest-growing opportunities within the global ACL/PCL reconstruction market through 2032?
  • How are adjustable loop cortical fixation devices reshaping fixation strategy, graft selection, and ASP growth across the fixation device market?
  • What is the commercial impact of sports industry partnerships on R&D investment, clinical evidence generation, and surgeon education programs?
  • How are allograft supply constraints shaping the balance between allograft and autograft use across global markets and patient populations?
  • What role are outpatient settings and ASC pricing dynamics playing in limiting device price growth and constraining premium product adoption?
  • Which companies lead each product segment and what are their core platforms, recent expansions, and strategic priorities?
  • How are quadriceps tendon grafts and compatible harvesting systems influencing product development investment across the market?
  • What are the key risks to growth, including allograft supply limitations, ASC pricing pressure, and reimbursement variability across global regions?

The Global ACL/PCL Reconstruction Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail. Use it to quantify demand, benchmark competitors, prioritize product development investments, and plan for growth across all major global regions.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

ACL/PCL Reconstruction Market

  • 8.1 Executive Summary
    • 8.1.1 Global ACL/PCL Reconstruction Market Overview
    • 8.1.2 Competitive Analysis
    • 8.1.3 Markets Included
    • 8.1.4 Regions Included
  • 8.2 Introduction
  • 8.3 Procedure Numbers
  • 8.4 Market Overview
    • 8.4.1 By Segment
    • 8.4.2 By Region
  • 8.5 Market Analysis And Forecast
    • 8.5.1 Total ACL/PCL Reconstruction Market
    • 8.5.2 Allograft Market
      • 8.5.2.1 BTB Allograft Market
      • 8.5.2.2 Non-Sutured Soft Tissue Allograft Market
      • 8.5.2.3 Pre-Sutured Soft Tissue Allograft Market
    • 8.5.3 Fixation Device Market
      • 8.5.3.1 Interference Screw Market
      • 8.5.3.2 Cortical Fixation Device Market
      • 8.5.3.3 Intratunnel Fixation Device Market
      • 8.5.3.4 Washer And Post Market
      • 8.5.3.5 Cross-Pin Market
  • 8.6 Drivers And Limiters
    • 8.6.1 Market Drivers
    • 8.6.2 Market Limiters
  • 8.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 8-1: ACL/PCL Reconstruction Market, Global, 2025 & 2032
  • Chart 8-2: ACL/PCL Reconstruction Procedures, Global, 2025
  • Chart 8-3: ACL/PCL Reconstruction Procedures by Region, Global, 2022 - 2032
  • Chart 8-4: ACL/PCL Reconstruction Market by Segment, Global, 2022 - 2032
  • Chart 8-5: ACL/PCL Reconstruction Market by Region, Global, 2022 - 2032
  • Chart 8-6: Leading Competitors, ACL/PCL Reconstruction Market, Global, 2025

LIST OF FIGURES

  • Figure 8-1: ACL/PCL Reconstruction Markets Covered
  • Figure 8-2: ACL/PCL Reconstruction Regions Covered, Global (1 of 2)
  • Figure 8-3: ACL/PCL Reconstruction Regions Covered, Global (2 of 2)
  • Figure 8-4: ACL/PCL Reconstruction Procedures by Region, Global, 2022 - 2032
  • Figure 8-5: ACL/PCL Reconstruction Procedures by Country, North America, 2022 - 2032
  • Figure 8-6: ACL/PCL Reconstruction Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 8-7: ACL/PCL Reconstruction Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 8-8: ACL/PCL Reconstruction Procedures by Country, Western Europe, 2022 - 2032
  • Figure 8-9: ACL/PCL Reconstruction Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 8-10: ACL/PCL Reconstruction Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 8-11: ACL/PCL Reconstruction Procedures by Country, Middle East, 2022 - 2032
  • Figure 8-12: ACL/PCL Reconstruction Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 8-13: ACL/PCL Reconstruction Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 8-14: ACL/PCL Reconstruction Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 8-15: ACL/PCL Reconstruction Procedures by Country, Africa, 2022 - 2032
  • Figure 8-16: ACL/PCL Reconstruction Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 8-17: ACL/PCL Reconstruction Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 8-18: Market Value by Region, ACL/PCL Reconstruction Market, Global, 2022 - 2032 (US$M)
  • Figure 8-19: ACL/PCL Allograft Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 8-20: Total ACL/PCL Allograft Market, Global, 2022 - 2032
  • Figure 8-21: Units Sold by Region, ACL/PCL Allograft Market, Global, 2022 - 2032
  • Figure 8-22: Average Selling Price by Region, ACL/PCL Allograft Market, Global, 2022 - 2032 (US$)
  • Figure 8-23: Market Value by Region, ACL/PCL Allograft Market, Global, 2022 - 2032 (US$M)
  • Figure 8-24: BTB Allograft Market, Global, 2022 - 2032
  • Figure 8-25: Units Sold by Region, BTB Allograft Market, Global, 2022 - 2032
  • Figure 8-26: Average Selling Price by Region, BTB Allograft Market, Global, 2022 - 2032 (US$)
  • Figure 8-27: Market Value by Region, BTB Allograft Market, Global, 2022 - 2032 (US$M)
  • Figure 8-28: Non-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032
  • Figure 8-29: Units Sold by Region, Non-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032
  • Figure 8-30: Average Selling Price by Region, Non-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032 (US$)
  • Figure 8-31: Market Value by Region, Non-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032 (US$M)
  • Figure 8-32: Pre-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032
  • Figure 8-33: Units Sold by Region, Pre-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032
  • Figure 8-34: Average Selling Price by Region, Pre-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032 (US$)
  • Figure 8-35: Market Value by Region, Pre-Sutured Soft Tissue Allograft Market, Global, 2022 - 2032 (US$M)
  • Figure 8-36: ACL/PCL Fixation Device Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 8-37: Total ACL/PCL Fixation Device Market, Global, 2022 - 2032
  • Figure 8-38: Units Sold by Region, ACL/PCL Fixation Device Market, Global, 2022 - 2032
  • Figure 8-39: Average Selling Price by Region, ACL/PCL Fixation Device Market, Global, 2022 - 2032 (US$)
  • Figure 8-40: Market Value by Region, ACL/PCL Fixation Device Market, Global, 2022 - 2032 (US$M)
  • Figure 8-41: Interference Screw Market, Global, 2022 - 2032
  • Figure 8-42: Units Sold by Region, Interference Screw Market, Global, 2022 - 2032
  • Figure 8-43: Average Selling Price by Region, Interference Screw Market, Global, 2022 - 2032 (US$)
  • Figure 8-44: Market Value by Region, Interference Screw Market, Global, 2022 - 2032 (US$M)
  • Figure 8-45: Cortical Fixation Device Market, Global, 2022 - 2032
  • Figure 8-46: Units Sold by Region, Cortical Fixation Device Market, Global, 2022 - 2032
  • Figure 8-47: Average Selling Price by Region, Cortical Fixation Device Market, Global, 2022 - 2032 (US$)
  • Figure 8-48: Market Value by Region, Cortical Fixation Device Market, Global, 2022 - 2032 (US$M)
  • Figure 8-49: Intratunnel Fixation Device Market, Global, 2022 - 2032
  • Figure 8-50: Units Sold by Region, Intratunnel Fixation Device Market, Global, 2022 - 2032
  • Figure 8-51: Average Selling Price by Region, Intratunnel Fixation Device Market, Global, 2022 - 2032 (US$)
  • Figure 8-52: Market Value by Region, Intratunnel Fixation Device Market, Global, 2022 - 2032 (US$M)
  • Figure 8-53: Washer and Post Market, Global, 2022 - 2032
  • Figure 8-54: Units Sold by Region, Washer and Post Market, Global, 2022 - 2032
  • Figure 8-55: Average Selling Price by Region, Washer and Post Market, Global, 2022 - 2032 (US$)
  • Figure 8-56: Market Value by Region, Washer and Post Market, Global, 2022 - 2032 (US$M)
  • Figure 8-57: Cross-Pin Market, Global, 2022 - 2032
  • Figure 8-58: Units Sold by Region, Cross-Pin Market, Global, 2022 - 2032
  • Figure 8-59: Average Selling Price by Region, Cross-Pin Market, Global, 2022 - 2032 (US$)
  • Figure 8-60: Market Value by Region, Cross-Pin Market, Global, 2022 - 2032 (US$M)
  • Figure 8-61: Leading Competitors, ACL/PCL Reconstruction Market, Global, 2025